Tetrahedral DNA Nanomaterial Regulates the Biological Behaviors of Adipose-Derived Stem Cells via DNA Methylation on Dlg3
Source abstract
Abstract
As a simple and classical three-dimensional shape, tetrahedral DNA nanostructures (TDNs) can provide robust properties for better stability and can serve as a versatile platform for biosensing and drug delivery. More in-depth, its safety should be assessed by sensitive detection methods. However, the effect of TDNs at the epigenetic level has not received much attention. Here, DNA methylation alteration in adipose-derived stem cells (ASCs) after exposure to TDNs was comprehensively evaluated. The results from reduced representation bisulfite sequencing, bisulfite-specific polymerase chain reaction, and further gene function analysis revealed that TDNs induced a few differentially methylated regions where negatively correlated gene expressions occur. Moreover, TDNs facilitated ASC proliferation and attenuated apoptosis via DNA hypermethylation of the Dlg3 gene promotor. This study may help pave the way for potential applications with the nanosafety of TDNs and offer deep insights into the proliferation promotion effect and antiapoptosis ability of TDNs.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Epigenetics and DNA Methylation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Southwest Medical University, Luzhou 646000, P. R. China
Funding
Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Sichuan Province Youth Science and Technology Innovation Team
References (51)
Show source-provided references
1. 10.1038/nnano.2011.18710.1038/nnano.2011.187 ↗
2. 10.1038/415062a10.1038/415062a ↗
3. 10.1073/pnas.163351510010.1073/pnas.1633515100 ↗
4. 10.1021/ja800554t10.1021/ja800554t ↗
5. 10.1021/acsami.8b0922210.1021/acsami.8b09222 ↗
6. 10.1002/adma.20100276710.1002/adma.201002767 ↗
7. 10.1021/ar400195t10.1021/ar400195t ↗
8. 10.1039/c3cc38693g10.1039/c3cc38693g ↗
9. 10.1038/nnano.2012.7310.1038/nnano.2012.73 ↗
10. 10.1021/nn200693a10.1021/nn200693a ↗
11. 10.1021/nn202774x10.1021/nn202774x ↗
12. 10.1126/science.121408110.1126/science.1214081 ↗
13. 10.1002/anie.20140323610.1002/anie.201403236 ↗
14. 10.1016/j.nano.2017.02.01110.1016/j.nano.2017.02.011 ↗
15. 10.1021/acsami.6b0652810.1021/acsami.6b06528 ↗
16. 10.1021/acsami.7b1792810.1021/acsami.7b17928 ↗
17. 10.1021/acsami.8b0262610.1021/acsami.8b02626 ↗
18. 10.1021/acsami.7b0478810.1021/acsami.7b04788 ↗
19. 10.1166/jbn.2017.245810.1166/jbn.2017.2458 ↗
20. 10.7150/thno.1612710.7150/thno.16127 ↗
21. 10.1002/adma.20160458010.1002/adma.201604580 ↗
22. 10.1101/gad.94710210.1101/gad.947102 ↗
23. 10.1146/annurev.biochem.74.010904.15372110.1146/annurev.biochem.74.010904.153721 ↗
24. 10.1111/cpr.1246710.1111/cpr.12467 ↗
25. 10.1016/j.devcel.2010.10.00510.1016/j.devcel.2010.10.005 ↗
26. 10.1038/boneres.2016.3710.1038/boneres.2016.37 ↗
27. 10.1038/boneres.2016.3310.1038/boneres.2016.33 ↗
28. 10.1073/pnas.152485711310.1073/pnas.1524857113 ↗
29. 10.3109/17435390.2015.102511510.3109/17435390.2015.1025115 ↗
30. 10.1038/boneres.2017.4810.1038/boneres.2017.48 ↗
31. 10.1097/00006534-200201000-0003010.1097/00006534-200201000-00030 ↗
32. 10.1038/ncb99010.1038/ncb990 ↗
33. 10.1002/(SICI)1097-0215(20000515)86:4<480::AID-IJC6>3.0.CO;2-610.1002/(SICI)1097-0215(20000515)86:4<480::AID-IJC6>3.0.CO;2-6 ↗
34. 10.1038/sj.onc.120674410.1038/sj.onc.1206744 ↗
35. 10.1126/science.275.5296.7310.1126/science.275.5296.73 ↗
36. 10.1038/sj.onc.120330910.1038/sj.onc.1203309 ↗
37. 10.1101/gad.187671010.1101/gad.1876710 ↗
38. 10.4161/cc.2667410.4161/cc.26674 ↗
39. 10.1056/NEJMra090121710.1056/NEJMra0901217 ↗
40. 10.1038/boneres.2017.2310.1038/boneres.2017.23 ↗
41. 10.1111/cpr.1234510.1111/cpr.12345 ↗
42. 10.1016/j.bbamcr.2003.11.00210.1016/j.bbamcr.2003.11.002 ↗
43. 10.1101/gad.130410510.1101/gad.1304105 ↗
44. 10.1073/pnas.080869110510.1073/pnas.0808691105 ↗
45. 10.1016/0092-8674(91)90362-310.1016/0092-8674(91)90362-3 ↗
46. 10.1016/j.bpj.2011.11.88310.1016/j.bpj.2011.11.883 ↗
47. 10.1038/cdd.2011.13810.1038/cdd.2011.138 ↗
48. 10.1126/science.277.5324.37010.1126/science.277.5324.370 ↗
49. 10.1101/cshperspect.a00865610.1101/cshperspect.a008656 ↗
50. O’Donovan N. · Clin. Cancer Res. · 2003 · 9 · 738
51. 10.1016/j.molcel.2015.03.00310.1016/j.molcel.2015.03.003 ↗